Updates on management of infection disease
2015-05-29
Julphar, along with key opinion leaders in Infectious Diseases, General Practitioners, Otolaryngology and Pediatricians from the Levant area (Lebanon, Iraq, Jordan) have met in an important event between 29th and 31st May, 2015, in Istanbul, Turkey.
The objective of the event was to discuss the Bacterial Resistance and the Management of various diseases. Julmentin and Triaxone (Enoxirt) were the featured Julphar medicines for this event."
.jpg)
